LONDON (Reuters) - Drug companies initiating clinical trials often use ghost authors and medical writers whose contributions are not credited in the research papers, Danish scientists said on Tuesday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback